Australia's most trusted
source of pharma news
Posted 29 January 2025 AM
AstraZeneca has continued its run to take the crown as the new perception leader in oncology, with HCPs ranking it the highest across five categories.
ZoomRx interviewed more than 300 oncologists, with 40 per cent of them in hemato-oncology, on their perception of 19 manufacturers of oncology treatments. The survey measured their perceptions on innovation, patient-centricity, reputation, HCP centricity, and promotional practices, with six countries contributing to the global score. The results were published in the Global Pharma Perception Report Oncology.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.